Energy sources identify metabolic phenotypes in pancreatic cancer. (Q38959840)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 20 September 2016

Language	Label	Description	Also known as
English	Energy sources identify metabolic phenotypes in pancreatic cancer.	scientific article published on 20 September 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

Europe PubMed Central

Energy sources identify metabolic phenotypes in pancreatic cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

11

object named as

Liang Liu

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

8

object named as

Jinfeng Xiang

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

9

object named as

Dingkong Liang

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Chen Liang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Yi Qin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Bo Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Shunrong Ji

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Wenyan Xu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jiang Liu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Qiangsheng Hu

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Chen Liu

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Quanxing Ni

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jin Xu

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

20 September 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Acta Biochimica et Biophysica Sinica

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

969-979

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

THE METABOLISM OF TUMORS IN THE BODY

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Glutamine addiction: a new therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Metabolic reprogramming: the emerging concept and associated therapeutic strategies

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Genetics and biology of pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Cancer statistics, 2016

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Biology and management of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Metabolic phenotypes in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Metabolism addiction in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Cancer cell metabolism: Warburg and beyond

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Stromal biology and therapy in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Pancreatic tumor cell metabolism: focus on glycolysis and its connected metabolic pathways

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Disrupting proton dynamics and energy metabolism for cancer therapy

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Energy metabolism in tumor cells

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Cancer metabolism: facts, fantasy, and fiction

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Glutamine and cancer: cell biology, physiology, and clinical opportunities

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Understanding the Warburg effect: the metabolic requirements of cell proliferation

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

A role for ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-induced insulin secretion

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Increased lipid metabolism and cell turnover of MiaPaCa2 cells induced by high-fat diet in an orthotopic system.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Alteration of strain background and a high omega-6 fat diet induces earlier onset of pancreatic neoplasia in EL-Kras transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Trans-10, cis-12 conjugated linoleic acid induced cell death in human colon cancer cells through reactive oxygen species-mediated ER stress

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

The metabolic features of normal pancreas and pancreatic adenocarcinoma: preliminary result of in vivo proton magnetic resonance spectroscopy at 3.0 T.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Metabolomic and transcriptomic profiling of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

The complex landscape of pancreatic cancer metabolism

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

PET/CT of cancer patients: part 1, pancreatic neoplasms

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Non-invasive vascular imaging: assessing tumour vascularity

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Dependence of FDG uptake on tumor microenvironment.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Intratumoral Heterogeneous F-18 Fluorodeoxyglucose Uptake Corresponds with Glucose Transporter-1 and Ki-67 Expression in a Case of Krukenberg Tumor: Localization of Intratumoral Hypermetabolic Focus by Fused PET/MR Image

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) --usefulness and limitations in "clinical reality".

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Circulating Metabolites and Survival Among Patients With Pancreatic Cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Targeting cellular metabolism to improve cancer therapeutics

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Targeting mitochondrial glutaminase activity inhibits oncogenic transformation

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Glycolysis inhibition for anticancer treatment

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Emerging metabolic targets in cancer therapy

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Control of gluconeogenesis by metformin: does redox trump energy charge?

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Fatty acid synthase as a potential therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Principles and current strategies for targeting autophagy for cancer treatment

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Modulation of oxidative stress as an anticancer strategy

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Exploiting the bad eating habits of Ras-driven cancers

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Hypoxia, HIF1 and glucose metabolism in the solid tumour

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Cancer as a metabolic disease: implications for novel therapeutics

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMW097

21 January 2018

Identifiers

10.1093/ABBS/GMW097

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27649892%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38959840&oldid=1745058686"